147 related articles for article (PubMed ID: 9649577)
41. Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects.
Hara M; Lindner TH; Paz VP; Wang X; Iwasaki N; Ogata M; Iwamoto Y; Bell GI
Diabetes; 1998 May; 47(5):845-6. PubMed ID: 9588461
[No Abstract] [Full Text] [Related]
42. Role of the D76N polymorphism of insulin promoter factor-1 in predisposing to Type 2 diabetes.
Owen KR; Evans JC; Frayling TM; Hattersley AT; McCarthy MI; Walker M; Hitman GA
Diabetologia; 2004 May; 47(5):957-8. PubMed ID: 15170499
[No Abstract] [Full Text] [Related]
43. Identification and functional analysis of c.422_423InsT, a novel mutation of the
Magaña-Cerino JM; Luna-Arias JP; Labra-Barrios ML; Avendaño-Borromeo B; Boldo-León XM; Martínez-López MC
Mol Genet Genomic Med; 2017 Jan; 5(1):50-65. PubMed ID: 28116330
[TBL] [Abstract][Full Text] [Related]
44. Area-preserving colour coding of inverse pole figure domain.
Karthikeyan T
J Microsc; 2017 Jul; 267(1):107-113. PubMed ID: 28470847
[TBL] [Abstract][Full Text] [Related]
45. Design of Miniaturized Electro Spray Instrument for Gene and Drug Therapeutic Treatment of IPF.
Fiave PA; Boehringer S; Gazdhar A; Geiser T; Hradetzky D
Biomed Tech (Berl); 2013 Aug; 58 Suppl 1():. PubMed ID: 24042641
[No Abstract] [Full Text] [Related]
46. PDX-1: A Promising Therapeutic Target to Reverse Diabetes.
Zhang Y; Fang X; Wei J; Miao R; Wu H; Ma K; Tian J
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551213
[TBL] [Abstract][Full Text] [Related]
47. How do I diagnose Maturity Onset Diabetes of the Young in my patients?
Colclough K; Patel K
Clin Endocrinol (Oxf); 2022 Oct; 97(4):436-447. PubMed ID: 35445424
[TBL] [Abstract][Full Text] [Related]
48. Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function.
Zhang M; Yang C; Zhu M; Qian L; Luo Y; Cheng H; Geng R; Xu X; Qian C; Liu Y
Diabetologia; 2021 May; 64(5):1144-1157. PubMed ID: 33569632
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases.
Goenka V; Borkar T; Desai A; Das RK
J Diabetes Metab Disord; 2020 Dec; 19(2):1979-1993. PubMed ID: 33520872
[TBL] [Abstract][Full Text] [Related]
50. Impact of Genetic Factors on the Age of Onset for Type 2 Diabetes Mellitus in Addition to the Conventional Risk Factors.
Piko P; Werissa NA; Fiatal S; Sandor J; Adany R
J Pers Med; 2020 Dec; 11(1):. PubMed ID: 33375163
[TBL] [Abstract][Full Text] [Related]
51. Neonatal Diabetes Mellitus.
Zübarioğlu AU; Bülbül A; Uslu HS
Sisli Etfal Hastan Tip Bul; 2018; 52(2):71-78. PubMed ID: 32595377
[TBL] [Abstract][Full Text] [Related]
52. Prediction algorithms: pitfalls in interpreting genetic variants of autosomal dominant monogenic diabetes.
Ellard S; Colclough K; Patel KA; Hattersley AT
J Clin Invest; 2020 Jan; 130(1):14-16. PubMed ID: 31815736
[No Abstract] [Full Text] [Related]
53. First Case Report of Maturity-Onset Diabetes of the Young Type 4 Pedigree in a Chinese Family.
Deng M; Xiao X; Zhou L; Wang T
Front Endocrinol (Lausanne); 2019; 10():406. PubMed ID: 31333579
[TBL] [Abstract][Full Text] [Related]
54. Point mutations in the PDX1 transactivation domain impair human β-cell development and function.
Wang X; Sterr M; Ansarullah ; Burtscher I; Böttcher A; Beckenbauer J; Siehler J; Meitinger T; Häring HU; Staiger H; Cernilogar FM; Schotta G; Irmler M; Beckers J; Wright CVE; Bakhti M; Lickert H
Mol Metab; 2019 Jun; 24():80-97. PubMed ID: 30930126
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
Wang X; Sterr M; Burtscher I; Chen S; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Cernilogar FM; Schotta G; Irmler M; Beckers J; Hrabě de Angelis M; Ray M; Wright CVE; Bakhti M; Lickert H
Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371
[TBL] [Abstract][Full Text] [Related]
56. Cooperative function of Pdx1 and Oc1 in multipotent pancreatic progenitors impacts postnatal islet maturation and adaptability.
Kropp PA; Dunn JC; Carboneau BA; Stoffers DA; Gannon M
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E308-E321. PubMed ID: 29351489
[TBL] [Abstract][Full Text] [Related]
57. Threshold-Dependent Cooperativity of Pdx1 and Oc1 in Pancreatic Progenitors Establishes Competency for Endocrine Differentiation and β-Cell Function.
Henley KD; Stanescu DE; Kropp PA; Wright CVE; Won KJ; Stoffers DA; Gannon M
Cell Rep; 2016 Jun; 15(12):2637-2650. PubMed ID: 27292642
[TBL] [Abstract][Full Text] [Related]
58. Assignment of Functional Relevance to Genes at Type 2 Diabetes-Associated Loci Through Investigation of β-Cell Mass Deficits.
O'Hare EA; Yerges-Armstrong LM; Perry JA; Shuldiner AR; Zaghloul NA
Mol Endocrinol; 2016 Apr; 30(4):429-45. PubMed ID: 26963759
[TBL] [Abstract][Full Text] [Related]
59. Differential effects on β-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes.
Lodh S; Hostelley TL; Leitch CC; O'Hare EA; Zaghloul NA
Hum Mol Genet; 2016 Jan; 25(1):57-68. PubMed ID: 26494903
[TBL] [Abstract][Full Text] [Related]
60. Diabetes Susceptibility Genes Pdx1 and Clec16a Function in a Pathway Regulating Mitophagy in β-Cells.
Soleimanpour SA; Ferrari AM; Raum JC; Groff DN; Yang J; Kaufman BA; Stoffers DA
Diabetes; 2015 Oct; 64(10):3475-84. PubMed ID: 26085571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
